Patents by Inventor Stephen F. Martin

Stephen F. Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210323913
    Abstract: Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, traumatic brain injury, and neuropathic pain.
    Type: Application
    Filed: April 29, 2017
    Publication date: October 21, 2021
    Inventors: Stephen F. MARTIN, James J. SAHN, Michael Dean WOOD
  • Publication number: 20210300903
    Abstract: Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, and neuropathic pain.
    Type: Application
    Filed: February 25, 2021
    Publication date: September 30, 2021
    Inventors: Stephen F. MARTIN, James J. SAHN, Kathryn Taylor LINKENS
  • Patent number: 11046670
    Abstract: Disclosed herein, inter alia, are piperazinyl norbenzom orphan compounds and uses thereof, including, for example, methods for treating a CNS disease, treating traumatic brain injury, improving cognition, or diagnosing and treating cancer.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: June 29, 2021
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Stephen F. Martin, James J. Sahn, Timothy R. Hodges
  • Patent number: 10954217
    Abstract: Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, and neuropathic pain.
    Type: Grant
    Filed: April 29, 2017
    Date of Patent: March 23, 2021
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Stephen F. Martin, James J. Sahn, Kathryn Taylor Linkens
  • Publication number: 20200115345
    Abstract: Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, and neuropathic pain.
    Type: Application
    Filed: October 16, 2019
    Publication date: April 16, 2020
    Inventors: Stephen F. MARTIN, James J. SAHN, Luisa SCOTT, Jonathan Thomas PIERCE-SHIMOMURA
  • Patent number: 10450275
    Abstract: Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, and neuropathic pain.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: October 22, 2019
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Stephen F. Martin, James J. Sahn, Luisa Scott, Jonathan Thomas Pierce-Shimomura
  • Publication number: 20190177301
    Abstract: Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, and neuropathic pain.
    Type: Application
    Filed: April 29, 2017
    Publication date: June 13, 2019
    Inventors: Stephen F. MARTIN, James J. SAHN, Kathryn Taylor LINKENS
  • Publication number: 20190077789
    Abstract: Disclosed herein, inter alia, are piperazinyl norbenzom orphan compounds and uses thereof, including, for example, methods for treating a CNS disease, treating traumatic brain injury, improving cognition, or diagnosing and treating cancer.
    Type: Application
    Filed: October 19, 2016
    Publication date: March 14, 2019
    Inventors: Stephen F. MARTIN, James J. SAHN, Timothy R. HODGES
  • Publication number: 20160280657
    Abstract: Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, and neuropathic pain.
    Type: Application
    Filed: December 22, 2015
    Publication date: September 29, 2016
    Inventors: Stephen F. Martin, James J. Sahn, Luisa Scott, Jonathan Thomas Pierce-Shimomura
  • Patent number: 3989691
    Abstract: 4-[3-(3-vinyl-1-acetyl-4-piperidyl)-1-propenyl]-6-methoxyquinoline, the corresponding epoxide and related compounds, useful in the synthesis of Cinchona alkaloids, are prepared by introducing an ylid group in the 4-position of a suitably substituted quinoline and reacting this ylid with an N-acetyl-4-piperidineacetaldehyde.
    Type: Grant
    Filed: January 9, 1975
    Date of Patent: November 2, 1976
    Assignee: Princeton University
    Inventors: Edward C. Taylor, Stephen F. Martin